These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1337808)

  • 1. [Adrenergic beta receptors and guanine nucleotide binding proteins (G-proteins) of the failing human heart].
    Böhm M; Schwinger RH; Erdmann E
    Z Kardiol; 1992; 81 Suppl 4():23-31. PubMed ID: 1337808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.
    Brodde OE; Hillemann S; Kunde K; Vogelsang M; Zerkowski HR
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S164-74. PubMed ID: 1355362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Gilbert EM; Sandoval A; Rasmussen R; Cates AE; Feldman AM
    Circulation; 1990 Aug; 82(2 Suppl):I12-25. PubMed ID: 2164894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-adrenergic receptors of the normal heart and in heart failure].
    Krasnikov TL; Gabrusenko SA
    Usp Fiziol Nauk; 2000; 31(2):35-50. PubMed ID: 10822833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation.
    Yamamoto J; Ohyanagi M; Morita M; Iwasaki T
    J Mol Cell Cardiol; 1994 May; 26(5):617-26. PubMed ID: 8072016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure.
    Böhm M
    Thorac Cardiovasc Surg; 1998 Sep; 46 Suppl 2():270-5; discussion 276. PubMed ID: 9822178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle.
    Skomedal T; Borthne K; Aass H; Geiran O; Osnes JB
    J Pharmacol Exp Ther; 1997 Feb; 280(2):721-9. PubMed ID: 9023284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic receptor systems in the failing and aging human heart: similarities and differences.
    Brodde OE; Leineweber K
    Eur J Pharmacol; 2004 Oct; 500(1-3):167-76. PubMed ID: 15464030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sympathetic nervous system in heart failure: effect of catecholamines and nitric oxide].
    Drexler H
    Z Kardiol; 1996; 85 Suppl 6():247-52. PubMed ID: 9064972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the sympathetic nervous system in heart failure].
    Dietz R; Osterziel KJ
    Z Kardiol; 1991; 80 Suppl 8():31-6. PubMed ID: 1665628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium.
    Feldman AM
    Circulation; 1993 May; 87(5 Suppl):IV27-34. PubMed ID: 8485831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of the cAMP-adenylate cyclase system in the failing human heart. Consequences for the therapy with inotropic drugs].
    Böhm M; Schwinger RH; Erdmann E
    Klin Wochenschr; 1990 Sep; 68(18):887-95. PubMed ID: 1979643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure.
    Katori T; Hoover DB; Ardell JL; Helm RH; Belardi DF; Tocchetti CG; Forfia PR; Kass DA; Paolocci N
    Circ Res; 2005 Feb; 96(2):234-43. PubMed ID: 15591228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation.
    Gando S; Hattori Y; Akaishi Y; Nishihira J; Kanno M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):475-84. PubMed ID: 9223590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of downregulation of beta-adrenergic receptors: perspective on the role of beta-adrenergic receptors in congestive heart failure.
    Frey MJ; Molinoff PB
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S13-8. PubMed ID: 2478805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of abnormal transmembrane signaling of the beta-adrenergic receptor in congestive heart failure.
    Horn EM; Bilezikian JP
    Circulation; 1990 Aug; 82(2 Suppl):I26-34. PubMed ID: 2164895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.